Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
trial source : Investor.assemblybio.com save search
Assembly Biosciences Announces Additional Promising Data from Phase 1a Clinical Trial Evaluating Highly Potent Next-Generation Core Inhibitor Candidate ABI-4334 and Provides Pipeline Update
Published: 2023-04-18 (Crawled : 12:00) - investor.assemblybio.com
ASMB | $12.95 0.23% 0.23% 17K
|
Health Technology
|
| O: -1.77%
H: 9.45%
C: -1.8%
abi-4334 candidate update pipeline trial
Assembly Biosciences Announces Promising Interim Results from Two Clinical Trials Evaluating Highly Potent Next-Generation Core Inhibitor Candidates ABI-H3733 and ABI-4334
Published: 2022-12-19 (Crawled : 13:00) - investor.assemblybio.com
ASMB | $12.95 0.23% 0.23% 17K
|
Health Technology
|
| O: 16.24%
H: 7.35%
C: -1.47%
abi-4334 trials results
Assembly Biosciences Doses First Subject in Phase 1a Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of Investigational Next Generation Core Inhibitor ABI-4334
Published: 2022-11-14 (Crawled : 13:00) - investor.assemblybio.com
ASMB | $12.95 0.23% 0.23% 17K
|
Health Technology
|
| O: 0.75%
H: 8.89%
C: 7.41%
abi-4334 trial
Assembly Biosciences Initiates Phase 1b Clinical Trial Evaluating Next Generation Core Inhibitor ABI-H3733 for the Treatment of Chronic Hepatitis B Virus Infection
Published: 2022-06-06 (Crawled : 12:00) - investor.assemblybio.com
ASMB | $12.95 0.23% 0.23% 17K
|
Health Technology
|
| O: 4.55%
H: 1.45%
C: -2.9%
treatment hepatitis virus trial infection infections phase 2b chronic hepatitis b
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.